228 related articles for article (PubMed ID: 35163003)
1. Cannabidiol Treatment Improves Glucose Metabolism and Memory in Streptozotocin-Induced Alzheimer's Disease Rat Model: A Proof-of-Concept Study.
de Paula Faria D; Estessi de Souza L; Duran FLS; Buchpiguel CA; Britto LR; Crippa JAS; Filho GB; Real CC
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163003
[TBL] [Abstract][Full Text] [Related]
2. Intranasal Insulin Ameliorates Cerebral Hypometabolism, Neuronal Loss, and Astrogliosis in Streptozotocin-Induced Alzheimer's Rat Model.
Chen Y; Guo Z; Mao YF; Zheng T; Zhang B
Neurotox Res; 2018 May; 33(4):716-724. PubMed ID: 28929339
[TBL] [Abstract][Full Text] [Related]
3. Spatial distribution of glucose hypometabolism induced by intracerebroventricular streptozotocin in monkeys.
Heo JH; Lee SR; Lee ST; Lee KM; Oh JH; Jang DP; Chang KT; Cho ZH
J Alzheimers Dis; 2011; 25(3):517-23. PubMed ID: 21471644
[TBL] [Abstract][Full Text] [Related]
4. Moderate protective effect of Kyotorphin against the late consequences of intracerebroventricular streptozotocin model of Alzheimer's disease.
Angelova H; Pechlivanova D; Krumova E; Miteva-Staleva J; Kostadinova N; Dzhambazova E; Landzhov B
Amino Acids; 2019 Nov; 51(10-12):1501-1513. PubMed ID: 31520285
[TBL] [Abstract][Full Text] [Related]
5. Cucurbitacin B exerts neuroprotection in a murine Alzheimer's disease model by modulating oxidative stress, inflammation, and neurotransmitter levels.
Liu Z; Kumar M; Kabra A
Front Biosci (Landmark Ed); 2022 Feb; 27(2):71. PubMed ID: 35227014
[TBL] [Abstract][Full Text] [Related]
6. Intracerebroventricular Streptozotocin Injections as a Model of Alzheimer's Disease: in Search of a Relevant Mechanism.
Grieb P
Mol Neurobiol; 2016 Apr; 53(3):1741-1752. PubMed ID: 25744568
[TBL] [Abstract][Full Text] [Related]
7. Synchronous nonmonotonic changes in functional connectivity and white matter integrity in a rat model of sporadic Alzheimer's disease.
Tristão Pereira C; Diao Y; Yin T; da Silva AR; Lanz B; Pierzchala K; Poitry-Yamate C; Jelescu IO
Neuroimage; 2021 Jan; 225():117498. PubMed ID: 33164858
[TBL] [Abstract][Full Text] [Related]
8. Cerebral Glucose Metabolism Assessment in Rat Models of Alzheimer's Disease: An 18F-FDG-PET Study.
Lu Y; Ren J; Cui S; Chen J; Huang Y; Tang C; Shan B; Nie B; Xinsheng L
Am J Alzheimers Dis Other Demen; 2016 Jun; 31(4):333-40. PubMed ID: 26631686
[TBL] [Abstract][Full Text] [Related]
9. Andrographolide Attenuates Short-Term Spatial and Recognition Memory Impairment and Neuroinflammation Induced by a Streptozotocin Rat Model of Alzheimer's Disease.
Souza LC; Andrade MK; Azevedo EM; Ramos DC; Bail EL; Vital MABF
Neurotox Res; 2022 Oct; 40(5):1440-1454. PubMed ID: 36029454
[TBL] [Abstract][Full Text] [Related]
10. 5-Hydroxytryptamine receptor 6 antagonist, SB258585 exerts neuroprotection in a rat model of Streptozotocin-induced Alzheimer's disease.
Hashemi-Firouzi N; Shahidi S; Soleimani-Asl S; Komaki A
Metab Brain Dis; 2018 Aug; 33(4):1243-1253. PubMed ID: 29667108
[TBL] [Abstract][Full Text] [Related]
11. Multi-target iron-chelators improve memory loss in a rat model of sporadic Alzheimer's disease.
Salkovic-Petrisic M; Knezovic A; Osmanovic-Barilar J; Smailovic U; Trkulja V; Riederer P; Amit T; Mandel S; Youdim MB
Life Sci; 2015 Sep; 136():108-19. PubMed ID: 26159898
[TBL] [Abstract][Full Text] [Related]
12. Anthocyanins as a potential pharmacological agent to manage memory deficit, oxidative stress and alterations in ion pump activity induced by experimental sporadic dementia of Alzheimer's type.
Pacheco SM; Soares MSP; Gutierres JM; Gerzson MFB; Carvalho FB; Azambuja JH; Schetinger MRC; Stefanello FM; Spanevello RM
J Nutr Biochem; 2018 Jun; 56():193-204. PubMed ID: 29587242
[TBL] [Abstract][Full Text] [Related]
13. Age- and Brain Region-Specific Changes of Glucose Metabolic Disorder, Learning, and Memory Dysfunction in Early Alzheimer's Disease Assessed in APP/PS1 Transgenic Mice Using
Li XY; Men WW; Zhu H; Lei JF; Zuo FX; Wang ZJ; Zhu ZH; Bao XJ; Wang RZ
Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27763550
[TBL] [Abstract][Full Text] [Related]
14. Effects of thymoquinone and memantine alone and in combination on memory and hippocampal morphology in rats with streptozotocin-induced Alzheimer's disease.
Özsoy Ş; Çakir Z; Akçay E; Gevrek F
Turk J Med Sci; 2023 Aug; 53(4):894-901. PubMed ID: 38031940
[TBL] [Abstract][Full Text] [Related]
15. Cerebrospinal fluid lactate levels and brain [18F]FDG PET hypometabolism within the default mode network in Alzheimer's disease.
Liguori C; Chiaravalloti A; Sancesario G; Stefani A; Sancesario GM; Mercuri NB; Schillaci O; Pierantozzi M
Eur J Nucl Med Mol Imaging; 2016 Oct; 43(11):2040-9. PubMed ID: 27221635
[TBL] [Abstract][Full Text] [Related]
16. Selenium prevents cognitive decline and oxidative damage in rat model of streptozotocin-induced experimental dementia of Alzheimer's type.
Ishrat T; Parveen K; Khan MM; Khuwaja G; Khan MB; Yousuf S; Ahmad A; Shrivastav P; Islam F
Brain Res; 2009 Jul; 1281():117-27. PubMed ID: 19374888
[TBL] [Abstract][Full Text] [Related]
17. Parallel ICA of FDG-PET and PiB-PET in three conditions with underlying Alzheimer's pathology.
Laforce R; Tosun D; Ghosh P; Lehmann M; Madison CM; Weiner MW; Miller BL; Jagust WJ; Rabinovici GD
Neuroimage Clin; 2014; 4():508-16. PubMed ID: 24818077
[TBL] [Abstract][Full Text] [Related]
18. Voxel-based analysis of Alzheimer's disease PET imaging using a triplet of radiotracers: PIB, FDDNP, and FDG.
Shin J; Lee SY; Kim SJ; Kim SH; Cho SJ; Kim YB
Neuroimage; 2010 Aug; 52(2):488-96. PubMed ID: 20385246
[TBL] [Abstract][Full Text] [Related]
19. Glucagon-like peptide-1 mediates effects of oral galactose in streptozotocin-induced rat model of sporadic Alzheimer's disease.
Knezovic A; Osmanovic Barilar J; Babic A; Bagaric R; Farkas V; Riederer P; Salkovic-Petrisic M
Neuropharmacology; 2018 Jun; 135():48-62. PubMed ID: 29501615
[TBL] [Abstract][Full Text] [Related]
20. The functional neuroanatomy of verbal memory in Alzheimer's disease: [
Staffaroni AM; Melrose RJ; Leskin LP; Riskin-Jones H; Harwood D; Mandelkern M; Sultzer DL
J Clin Exp Neuropsychol; 2017 Sep; 39(7):682-693. PubMed ID: 27876444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
